HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis.
Bukrinsky
Michael
M
Sviridov
Dmitri
D
D000818:Animals; D019380:Anti-HIV Agents / Q000009:adverse effects; D001161:Arteriosclerosis / Q000209:etiology* / Q000473:pathology; D001692:Biological Transport; D002784:Cholesterol / Q000378:metabolism; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D050171:Dyslipidemias / Q000139:chemically induced; D005487:Foam Cells / Q000473:pathology / Q000821:virology; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008264:Macrophages / Q000473:pathology* / Q000821:virology; D051379:Mice; D008954:Models, Biological
D019380:Anti-HIV Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D002784:Cholesterol